Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,800,013
-
Share change
-
+370,484
-
Total reported value
-
$296,372,261
-
Price per share
-
$21.52
-
Number of holders
-
36
-
Value change
-
+$7,815,917
-
Number of buys
-
19
-
Number of sells
-
11
Institutional Holders of SATSUMA PHARMACEUTICALS INC - COM (STSA) as of Q1 2020
As of 31 Mar 2020,
SATSUMA PHARMACEUTICALS INC - COM (STSA) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,800,013 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., WELLINGTON MANAGEMENT GROUP LLP, TPG Group Holdings (SBS) Advisors, Inc., CITADEL ADVISORS LLC, EVENTIDE ASSET MANAGEMENT, LLC, Cormorant Asset Management, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., CAXTON CORP, VANGUARD GROUP INC, and BlackRock Inc..
This page lists
36
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.